Ramzi Benamar
Director of Finance/CFO chez BELLUS HEALTH
Profil
Ramzi Benamar is currently the Chief Financial Officer at BELLUS Health, Inc. He previously held the same position at DBV Technologies SA in 2020 and was the Vice President & Head-Financial Planning Analysis at Spark Therapeutics, Inc. from 2017 to 2020.
Prior to that, he was the Head-Research & Development at Purdue Pharmaceuticals LP from 2015 to 2017.
Mr. Benamar has an undergraduate degree and an MBA from Temple University (Pennsylvania) and a graduate degree from the University of the Sciences in Philadelphia.
Postes actifs de Ramzi Benamar
| Sociétés | Poste | Début |
|---|---|---|
| BELLUS HEALTH | Director of Finance/CFO | 07/12/2020 |
Anciens postes connus de Ramzi Benamar
| Sociétés | Poste | Fin |
|---|---|---|
| DBV TECHNOLOGIES | Director of Finance/CFO | 02/10/2020 |
| SPARK THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2020 |
Purdue Pharmaceuticals LP
 Purdue Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology Part of Purdue Pharma LP, Purdue Pharmaceuticals LP is a physician-founded and physician-led company that develops, manufactures, and markets medications and consumer health products. Purdue Pharmaceuticals is based in Wilson, NC and offers a diverse product line. The private company is committed to supporting collaborations to drive innovations in patient care while addressing the opioid addiction crisis. | Chief Tech/Sci/R&D Officer | 01/01/2017 |
Formation de Ramzi Benamar
| Temple University (Pennsylvania) | Masters Business Admin |
| University of the Sciences in Philadelphia | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| DBV TECHNOLOGIES | Health Technology |
| Entreprise privées | 3 |
|---|---|
BELLUS Health, Inc.
 BELLUS Health, Inc. Pharmaceuticals: MajorHealth Technology BELLUS Health, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of cough hypersensitivity and other hypersensitization disorders. Its product BLU-5937, is being developed for the treatment of chronic cough and chronic pruritus, or chronic itch. The company was founded on June 17, 1993 and is headquartered in Laval, Canada. | Health Technology |
Spark Therapeutics, Inc.
 Spark Therapeutics, Inc. BiotechnologyHealth Technology Spark Therapeutics, Inc. engages in the research, development, and commercialization of gene therapies. Its product portfolio intends to treat inherited retinal sickness, liver-mediated, and neurodegenerative diseases. The company was founded by Jean Bennett, Beverly Davidson, Katherine A. High, Jeffrey D. Marrazzo, J. Fraser Wright, and Jennifer Wellman on March 13, 2013 and is headquartered in Philadelphia, PA. | Health Technology |
Purdue Pharmaceuticals LP
Purdue Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology Part of Purdue Pharma LP, Purdue Pharmaceuticals LP is a physician-founded and physician-led company that develops, manufactures, and markets medications and consumer health products. Purdue Pharmaceuticals is based in Wilson, NC and offers a diverse product line. The private company is committed to supporting collaborations to drive innovations in patient care while addressing the opioid addiction crisis. | Health Technology |
